142 related articles for article (PubMed ID: 17005433)
1. Specific changes in the proteomic pattern produced by the BRCA1-Ser1841Asn missense mutation.
Crugliano T; Quaresima B; Gaspari M; Faniello MC; Romeo F; Baudi F; Cuda G; Costanzo F; Venuta S
Int J Biochem Cell Biol; 2007; 39(1):220-6. PubMed ID: 17005433
[TBL] [Abstract][Full Text] [Related]
2. Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomas.
Yoshikawa K; Ogawa T; Baer R; Hemmi H; Honda K; Yamauchi A; Inamoto T; Ko K; Yazumi S; Motoda H; Kodama H; Noguchi S; Gazdar AF; Yamaoka Y; Takahashi R
Int J Cancer; 2000 Oct; 88(1):28-36. PubMed ID: 10962436
[TBL] [Abstract][Full Text] [Related]
3. Missense mutations of BRCA1 gene affect the binding with p53 both in vitro and in vivo.
Quaresima B; Faniello MC; Baudi F; Crugliano T; Di Sanzo M; Cuda G; Costanzo F; Venuta S
Oncol Rep; 2006 Oct; 16(4):811-5. PubMed ID: 16969499
[TBL] [Abstract][Full Text] [Related]
4. RNA analysis reveals splicing mutations and loss of expression defects in MLH1 and BRCA1.
Sharp A; Pichert G; Lucassen A; Eccles D
Hum Mutat; 2004 Sep; 24(3):272. PubMed ID: 15300854
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
[TBL] [Abstract][Full Text] [Related]
6. Effects on human transcriptome of mutated BRCA1 BRCT domain: a microarray study.
Iofrida C; Melissari E; Mariotti V; Guglielmi C; Guidugli L; Caligo MA; Pellegrini S
BMC Cancer; 2012 May; 12():207. PubMed ID: 22646717
[TBL] [Abstract][Full Text] [Related]
7. Structure-based assessment of missense mutations in human BRCA1: implications for breast and ovarian cancer predisposition.
Mirkovic N; Marti-Renom MA; Weber BL; Sali A; Monteiro AN
Cancer Res; 2004 Jun; 64(11):3790-7. PubMed ID: 15172985
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 5083del19 mutant allele selectively up-regulates periostin expression in vitro and in vivo.
Quaresima B; Romeo F; Faniello MC; Di Sanzo M; Liu CG; Lavecchia A; Taccioli C; Gaudio E; Baudi F; Trapasso F; Croce CM; Cuda G; Costanzo F
Clin Cancer Res; 2008 Nov; 14(21):6797-803. PubMed ID: 18980973
[TBL] [Abstract][Full Text] [Related]
9. Different Array CGH profiles within hereditary breast cancer tumors associated to BRCA1 expression and overall survival.
Alvarez C; Aravena A; Tapia T; Rozenblum E; Solís L; Corvalán A; Camus M; Alvarez M; Munroe D; Maass A; Carvallo P
BMC Cancer; 2016 Mar; 16():219. PubMed ID: 26979459
[TBL] [Abstract][Full Text] [Related]
10. Characterization of BRCA1 and BRCA2 variants found in a Norwegian breast or ovarian cancer cohort.
Jarhelle E; Riise Stensland HM; Mæhle L; Van Ghelue M
Fam Cancer; 2017 Jan; 16(1):1-16. PubMed ID: 27495310
[TBL] [Abstract][Full Text] [Related]
11. Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach.
Tischkowitz M; Hamel N; Carvalho MA; Birrane G; Soni A; van Beers EH; Joosse SA; Wong N; Novak D; Quenneville LA; Grist SA; ; Nederlof PM; Goldgar DE; Tavtigian SV; Monteiro AN; Ladias JA; Foulkes WD
Eur J Hum Genet; 2008 Jul; 16(7):820-32. PubMed ID: 18285836
[TBL] [Abstract][Full Text] [Related]
12. Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotation.
Fernandes VC; Golubeva VA; Di Pietro G; Shields C; Amankwah K; Nepomuceno TC; de Gregoriis G; Abreu RBV; Harro C; Gomes TT; Silva RF; Suarez-Kurtz G; Couch FJ; Iversen ES; Monteiro ANA; Carvalho MA
J Biol Chem; 2019 Apr; 294(15):5980-5992. PubMed ID: 30765603
[TBL] [Abstract][Full Text] [Related]
13. In vitro analysis of genomic instability triggered by BRCA1 missense mutations.
Quaresima B; Faniello MC; Baudi F; Crugliano T; Cuda G; Costanzo F; Venuta S
Hum Mutat; 2006 Jul; 27(7):715. PubMed ID: 16786532
[TBL] [Abstract][Full Text] [Related]
14. Proteomics of mouse BRCA1-deficient mammary tumors identifies DNA repair proteins with potential diagnostic and prognostic value in human breast cancer.
Warmoes M; Jaspers JE; Pham TV; Piersma SR; Oudgenoeg G; Massink MP; Waisfisz Q; Rottenberg S; Boven E; Jonkers J; Jimenez CR
Mol Cell Proteomics; 2012 Jul; 11(7):M111.013334. PubMed ID: 22366898
[TBL] [Abstract][Full Text] [Related]
15. Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents.
Andres JL; Fan S; Turkel GJ; Wang JA; Twu NF; Yuan RQ; Lamszus K; Goldberg ID; Rosen EM
Oncogene; 1998 Apr; 16(17):2229-41. PubMed ID: 9619832
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility - A proteomics study.
Gau DM; Lesnock JL; Hood BL; Bhargava R; Sun M; Darcy K; Luthra S; Chandran U; Conrads TP; Edwards RP; Kelley JL; Krivak TC; Roy P
Cell Cycle; 2015; 14(12):1884-92. PubMed ID: 25927284
[TBL] [Abstract][Full Text] [Related]
17. The effects of BRCA1 missense variants V1804D and M1628T on transcriptional activity.
Ostrow KL; McGuire V; Whittemore AS; DiCioccio RA
Cancer Genet Cytogenet; 2004 Sep; 153(2):177-80. PubMed ID: 15350310
[TBL] [Abstract][Full Text] [Related]
18. Characterization of cancer-linked BRCA1-BRCT missense variants and their interaction with phosphoprotein targets.
Drikos I; Nounesis G; Vorgias CE
Proteins; 2009 Nov; 77(2):464-76. PubMed ID: 19452558
[TBL] [Abstract][Full Text] [Related]
19. Functional Analyses of Rare Germline Missense
Hovland HN; Mchaina EK; Høberg-Vetti H; Ariansen SL; Sjursen W; Van Ghelue M; Haukanes BI; Knappskog PM; Aukrust I; Ognedal E
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833189
[TBL] [Abstract][Full Text] [Related]
20. Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance.
Langerud J; Jarhelle E; Van Ghelue M; Ariansen SL; Iversen N
Hum Genomics; 2018 Nov; 12(1):51. PubMed ID: 30458859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
